BiON : Annual Report & Accounts 2019

Content Pages

2

Directors, Secretary and Advisers

DIRECTORS:

Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah : Non-Executive Chairman (effective 30 April 2020)

JERSEY HEADQUARTERS / REGISTERED OFFICE:

12 Castle Street, St. Helier, Jersey JE2 3RT

Channel Islands

Tel: +44 (0) 1534 847406

Fax: +44 (0) 1534 847001

COMPANY SECRETARY:

Apex Financial Services (Jersey) Limited

12 Castle Street, St. Helier, Jersey JE2 3RT

Channel Islands

CORPORATE HEADQUARTERS / MALAYSIA OFFICE:

D2-3-1 Solaris Dutamas 1, Jalan Dutamas 1, 50480 Kuala Lumpur

Malaysia

Tel: +603 6413 1085

Fax: +603 6413 1086

Website: http://www.bionplc.com

NOMINATED ADVISER:

Beaumont Cornish

Building 3, 566 Chiswick High Road, London W4 5YA

United Kingdom

Tel: +44 (0) 207 628 3396

BROKER:

Optiva Securities Ltd

49 Berkeley Square, London W1J 5AZ

United Kingdom

Tel: +44 (0) 203 137 1902

FINANCIAL PR ADVISER:

Luther Pendragon

48 Gracechurch Street, London EC3V 0EJ

United Kingdom

AUDITORS:

Haysmacintyre LLP

10 Queen Street Place, London EC4R 1AG, United Kingdom

REGISTRAR:

Link Market Services (Jersey) Limited

12 Castle Street, St. Helier, Jersey JE2 3RT, Channel Island

PRINCIPAL BANKERS:

Malayan Banking Berhad,

77 Queen Victoria Street, London EC4V 4AY

CIMB Bank Berhad

Plaza Damansara, Menara Southern Bank,

83, Medan Setia 1, Plaza Damansara,

Bukit Damansara, 50490 Kuala Lumpur

3

Financial Summary

• Revenue was RM24.06m (2018: RM1.92m)
• Gross profit was RM3.05m (2018: loss of RM1.84m)
• Gross margin was 12.7% (2018: negative 95.6%)
• Operating profit was RM0.66m (2018: loss RM11.65m)
• Profit before tax was RM1.11m (2018: loss RM13.65m)
• Cash and cash equivalents at 31 December 2019 were RM0.08m (31 December 2018: RM0.47m)

Operational Summary

• Established itself as the only company in Malaysia to operate plants with two different biogas systems - tank and lagoon - under the Feed-in-Tariff ("FiT") mechanism
• Progress on projects in H1 2019 was impacted by financial constraints
• The Group's second fully-owned biogas power plant, the 2.0MW Malpom plant, commenced selling power to the national electricity grid at the full tariff rate in H2 2019
• Recommenced pursuing engineering, procurement, construction and commissioning ("EPCC") opportunities and successfully secured a number of contracts before year end, including working on biogas power plants owned by Megagreen Energy Sdn Bhd ("MGE") as well as some small infrastructure projects with other customers

Outlook

• Post year end, BiON Plc ("BiON") has been impacted by the COVID-19 pandemic as the public lockdown required construction activities to cease at project sites. However, BiON implemented a number of cost mitigation measures through Government support and engagement with its clients, vendors and suppliers, which provided sufficient liquidity until operations could resume
• BiON is continuing to source EPCC projects while completing work on its two biogas power plants ("BPPs"), at Kahang and Malpom, to enable the return to full operations by year end
• As announced on 22 September 2020, post period, through its subsidiary, BiON Sdn Bhd, the Group has conditionally acquired two BPPs from MGE. BiON expects these BPPs to be completed and commence commercial operations by year end, subject to the receipt of approval from the relevant authorities
• Looking further ahead, BiON intends to increase the installed capacity of its biogas power plants portfolio via strategic acquisitions and partnerships with other biogas players in Malaysia to achieve greater economies of scale
• In addition, the Group intends to expand its capabilities and offerings in the coming years by entering into complementary renewable energy segments such as biomass, landfill biogas, solar power and waste-to- energy products and environmental engineering services. This includes entering into partnerships with businesses located in other countries in Southeast Asia

4

Chairman's Statement

I am very pleased to be presenting my maiden Annual Report and Accounts since my appointment as Chairman of the Board of BiON plc on 30 April 2020. Of course, the reporting year ended 31 December 2019 was presided over by Datuk Dr. Haji Radzali. I am delighted he has chosen to stay on as a Senior Independent Non-Executive Director. I am eager to contribute my knowledge and experience to the Company as we commence deploying our growth strategy.

In the first half of 2019, financial constraints slowed down the progress of our projects and business activities, however, the second half of the year saw a return to normalised trading as our Malpom biogas power plant recommenced selling power to the national grid at the full tariff rate which helped our cashflow position. Towards the end of the year, we were able to secure projects which contributed to a year-on-year increase in revenues compared to the previous year.

We were hoping to carry the momentum forward into the new year, however, the pandemic did stall that. I am immensely proud of the Group, as we achieved retaining full employment without furloughing any of our employees and participated on the Malaysian Government's economic stimulus package programs, which greatly helped to sustain our business activities throughout this time. To further safeguard our reserves, we also revised our payment plans and terms with our creditors and suppliers as well as engaging our clients to address any issues that may arise regarding our payment procedures during the lockdown period.

The Company is pursuing its business restructuring plans and transformation activities and changed its name to BiON plc in May 2020 - a name that captures the ethos of the company, ecological sustainability and conservation through harnessing progressive energy. It also reflects the future direction of the Group.

Pursuing Opportunities in Renewable Energy

We are encouraged by the continuing support of the Government for its numerous initiatives to progress Malaysia's renewable energy sector further. The Feed-in-Tariff ("FiT") scheme was revised with the introduction of the FiT e-Bidding system, which promoted an open and transparent online bidding system for biogas applications and an extension of the FiT tenure from 16 years to 21 years to optimize the Government's Renewable Energy Fund utilisation.

Additionally, the Government had introduced an exciting new initiative i.e. the Net Energy Metering 2.0 ("NEM") program which permits the sale of excess power to the grid on a one-for-one basis versus grid power kilowatts consumed and targets mainly commercial and industrial installations.

The board is looking at expanding the Group's activities into other renewable energy projects beyond biogas from palm oil mill effluent ("POME") and I look forward to reporting on this at the appropriate time. With the Group's business expansion plans underway, we do intend to grow and expand not just our activities in the renewable energy sector, but also to enhance our resources and talent pool, advance our technical capabilities and strengthen our infrastructure further.

The Company foresees that embarking on potential joint-ventures, future mergers or acquisitions in similar or new renewable energy initiatives will most certainly help strengthen its positioning in the long term. We are optimistic and confident that BiON will become the renewable energy industry's environmental engineering market leader and preferred green technology provider in the next three to five years.

Corporate Governance

The Board continues to uphold and maintain good corporate governance. Board meetings are where decisions are taken and the Executive Directors are in close contact with our new Nomad, Beaumont Cornish Limited and our new brokers, Optiva Securities.

Post year end, Mr. Saravanan Rasaratnam and Mr. Navindran Balakrishnan, stepped down from their roles as Chief Executive Officer and Chief Operating Officer respectively on 31 January 2020. We thank them for their immense contribution in taking the Company to where it is today. Our special thanks to Datuk Dr. Haji Radzali for steering the company over the past four years as Non-Executive Chairman and I am very honored to have

5

him continue his tenure with us as a Senior Independent Non-Executive Director. I also welcome the appointment of Mr. Habizan Rahman, as Executive Director to the Company's Board.

To conclude, I would like to thank our clients, partners and shareholders for their continued support towards the Company. My sincere appreciation goes out to all the employees for weathering this year's storm not as a Company but as a family - I believe that the future ahead will be bright and boundless for the Company and as one, we can accomplish greater things together.

Datuk Dr. Ir. Ts. Mohd. Abdul Karim Abdullah

Non-Executive Chairman

30 September 2020

6

Chief Executive Officer's Review

The Group is one of Malaysia's leading environmental engineering, renewable energy and green technology solutions providers. Currently, its business focus is to construct, operate and own biogas power generation plants in Malaysia, derived namely from the treatment of POME and other wastes produced in the processing of palm oil at palm oil mills. The biogas generated (i.e. methane) is converted into electricity to be sold to the Malaysian National Grid under a long-term renewable energy power purchase agreement. Aside from this, the Group provides similar services to third parties through EPCC contracts.

During the first half of 2019, the Group was hampered in its efforts to progress its projects due to financial constraints, which also prevented the completion of the upgrading works at its Kahang plant.

However, in the second half of the year, BiON established itself as the only company in Malaysia to operate plants with two different biogas systems - tank and lagoon - under the FiT mechanism with its second fully-owned biogas power plant, the 2.0MW Malpom plant, commencing power sales to the national electricity grid at the full tariff rate. This improved the Group's cash flow, which enabled BiON to resume its other business activities.

This included recommencing pursuing EPCC opportunities, with a number of contracts secured by year end. In particular, towards the end of the year, BiON received a variation order from MGE for upgrading works at its Seberang Perak and Nasarudin biogas power plants that amounted to RM20.5m along with several small infrastructure projects from other customers.

COVID-19 Update

Post year-end, following the outbreak of COVID-19, on 18 March 2020 the Government of Malaysia implemented a Movement Control Order ("MCO"), which was the lockdown and restriction of movement for all civilians and non-essential businesses, including a ban on interstate travel. This required the Group to cease its construction activities at the various project sites as supplies, materials and equipment were not transportable or obtainable.

As of 4 May 2020, the Government of Malaysia transitioned the MCO to a Conditional Movement Control Order ("CMCO"), which allowed certain business sectors and companies to resume operations within continued strict parameters regarding social distancing. Consequently, the Group commenced resuming its operations in a phased manner. Interstate border control was still in place and so, while employees were permitted to travel to the project sites with a Letter of Authority from the Company, the movement of resources, materials and equipment to sites or offices progressed slowly. The CMCO was subsequently uplifted on 10 June 2020 and transitioned to a Recovery Movement Control Order ("RMCO"). Under the RMCO, which will be effective until the end of 2020, interstate travel is allowed, and most sectors have been permitted to reopen while ensuring adherence to certain Standard Operating Procedures. This enabled BiON to increase its activity and resume work on upgrading its plants in Kahang, Johor and Malpom, Penang. Management anticipates that the plants will return to optimal operational efficiency before the end of 2020.

The Group implemented a number of mitigating measures to support cash flows during this period of reduced trading. This included participating in the Social Security Organisation's Wage Subsidy Programme, which was introduced under the Government of Malaysia's Prihatin Rakyat Economic Stimulus package to help businesses affected by the COVID-19 outbreak by paying towards employees' wages. The Group is working with its creditors or suppliers to revise and renegotiate payment terms, in a manner acceptable to all parties, either through postponing payments, devising a staggered payment plan or revising the existing payment plan. The Group is also engaging with its customers to address any issues regarding payment procedures. The Group has continued financial support from Serba Dinamik Sdn Bhd, which will be called upon if required to continue to meet its liabilities.

7

Outlook

As noted, the COVID-19 outbreak is causing significant disruption to BiON's business in 2020 due to the public lockdown. However, as restrictions have been eased, activity is increasingly resuming. In addition, with the cost mitigation measures implemented during the period of reduced trading along with the securing of financing - from the Government and third party loans - the Board continues to believe that the Group remains viable for the foreseeable future.

BiON is continuing to source EPCC projects while also completing work on its BPPs at Kahang and Malpom, which is expected to enable them to return to full operational efficiency by year end.

As announced on 22 September 2020, through its subsidiary, BiON Sdn Bhd, the Company has conditionally acquired two BPPs, Nasarudin and Seberang Perak (both in Perak, Malaysia), from MGE. BiON expects these BPPs to be completed and commence commercial operations by year end, subject to the receipt of approval from the relevant authorities. This acquisition, with a combined installed capacity of 3.0MW, increases the Group's total installed capacity to 7.0MW.

Looking further ahead, while continuing to develop POME-based biogas power plants, the Board intends to expand its business activities into complementary renewable energy sectors.

The Board believes in creating waste-to-value and that there are abundant opportunities in eco-friendly sustainable ventures such as biomass, solar, industrial and wastewater treatment, landfill biogas, livestock waste and more. The Group intends to target these opportunities by leveraging its significant experience and track record in waste-to-energy and environmental engineering as well as by pursuing strategic partnerships, joint ventures and acquisitions, including expanding its EPCC offer to other countries in Southeast Asia.

As a result, the Board continues to look to the future with confidence and to delivering a sustainable future.

Tuan Syed Nazim Syed Faisal

Executive Director & Chief Executive Officer

30 September 2020

8

Chief Financial Officer's Review

BiON achieved a strong increase in revenue in 2019 and improved its gross margin. As a result, BiON managed to generate a profit before tax compared to a loss for the prior year.

Revenue

Revenue for the year ended 31 December 2019 was RM24.06m (15 months to 31 December 2018: RM1.92m), which was primarily generated by the provision of EPCC services and the sale of electricity from our Malpom plant, which contributed to revenue at the full tariff rate. The Company also completed a number of small infrastructure projects under EPCC contracts.

Gross Profit/(Loss) & Margin

The gross profit for the financial year ended 31 December 2019 was RM3.05m, with a gross margin of 12.7% (2018: gross loss of RM1.84m; gross loss margin of negative 95.6%). This reflects the higher revenue for 2019 and the improvement in our cost management.

Profit/(Loss)

There was an operating profit for the year of RM0.66m (2018: loss RM11.65m). This improved performance was due to a significant increase in revenue and the one-off waiver of the amount payable to previous Directors. The profit before tax was at RM1.11m (2018: loss RM13.65m). As a result, BiON managed to generate an operating profit while reducing the Group's overall loss for the year.

During the year there was a one-off waive of the amounts payable to previous Directors and other creditors. This had a positive impact on other income of RM6,329k.

Earnings/(Loss) Per Share

On a consolidated level, the Group's basic loss per share for the year ended 31 December 2019 was RM0.001 (2018: loss RM0.04 per share) based on the weighted number of ordinary shares.

Taxation

BiON Sdn Bhd, the operating entity of the Group, is a BioNexus Status Company granted by Malaysian Bioeconomy Development Corporation Sdn Bhd. This company was entitled to an income tax exemption on the statutory business income derived from approved activities over five consecutive years of assessment commencing from the first year in which BiON Sdn Bhd generates statutory income from relevant approved activities. The tax exemption has since expired in the financial period ended 31 December 2018. At the end of December 2019, the Company became subject to a concessionary tax rate of 24% for the next 10 years on its taxable profits.

Cash Flow

Cash and cash equivalents at 31 December 2019 were RM0.08m (2018: RM0.47m).

On 23 May 2019, the Group procured a 12-month mezzanine loan of approximately RM8.40m with no interest charged, for working capital purposes, from a director of the Company, Syed Nazim Syed Faisal. The drawdown was in tranches and as at the end of the reporting period, the full amount was drawn down. As at year end, the principle remains outstanding. On 24 January 2020, the full amount was then converted into ordinary shares of BiON plc.

On 13 August 2019, the Group further procured a 6-month mezzanine loan of approximately RM0.51m with interest of 1.5% per month, for working capital purposes and full drawdown was made during the year.

9

Receivables

During the year, the Group continued to maintain its repayment arrangements that were structured with MGE and Concord Green Energy Sdn Bhd ("CGE"). However, the amounts outstanding from both accounts have remained long overdue.

Discussions are taking place with CGE to re-negotiate the terms of repayment and in the meantime, Serba Dinamik Sdn Bhd and one of the executive directors have guaranteed the value of the debt.

The amount due from MGE was partly recovered from the Group's purchase of two biogas power plants from the Company as announced on 22 September 2020. The Group's management continue to be in talks with both parties to arrive at an amicable settlement for the remaining amounts, including negotiations to acquire three biogas power plants, which is expected to be finalised upon satisfactory outcome from the due diligence exercise.

Fakrizzaki Ghazali

Chief Financial Officer

30 September 2020

10

Directors' Biographies

DATO' DR. IR. TS. MOHD ABDUL KARIM ABDULLAH

Non-Executive Chairman

Dato' Dr. Ir. Ts. Mohd Abdul Karim was appointed to the Board on 30 April 2020 to serve as Non-Executive Chairman of the Group, replacing YBhg. Datuk Dr. Haji Radzali Hassan who had held the post since May 2016. He chairs the Nomination Committee and is a member of the Audit, Remuneration and Compliance Committees.

He is a self-made entrepreneur with an illustrious engineering career spanning 31 years started with Asean Bintulu Fertilizer Sdn Bhd (1988) as a Mechanical Engineer. Later, he was appointed as the Coordinator for the Ammonia and Rotary 5th turnaround Preparation Team (1990) and as a Rotating Equipment Area Engineer (1991).

In 1993, Dato' Dr. Ir. Ts. Mohd Abdul Karim formed Serba Dinamik and assumed the position as the Group Chief Executive Officer. He has helmed the company and overseen its growth to become an international energy services group with a market value of approximately RM5.3 billion.

Dato' Dr. Ir. Ts. Mohd Abdul Karim holds a Bachelor's Degree in Mechanical Engineering from Universiti Teknologi Malaysia, an Honorary PhD in Industrial Engineering from InterAmerican University, USA in 2009 and a PhD in Entrepreneurship from Golden State University, USA in 2012.

He is a member of the Institution of Engineers Malaysia since 1994, a registered member of the Board of Engineers Malaysia since 1996 and a member of the ASEAN Federation of Engineering Organization since 2002.

DATUK DR. HAJI RADZALI HASSAN

Senior Independent Non-Executive Director

Datuk Dr. Haji Radzali Hassan is a pioneering environmental entrepreneur and currently serves as a Senior Independent Non-Executive Director of the Group. He has been with the Board since 6 May 2016 and stepped down as its Chairman on 30 April 2020. He chairs the Audit and Remuneration Committees and is a member of the Nomination and Compliance Committees.

He holds a DBA from Warsaw Management University, MBA from Cambridge International University and received his certification as a Certified Professional Manager from the University Institute for International and European Studies.

Datuk Dr. Haji Radzali is currently the Chairman / Group Managing Director of Harta Maintenance Sdn. Bhd and the Harta Group of Companies - a post he has held since April 1980. He also helms the role as Director in several subsidiary companies of Suiwah Corporation Berhad and is a major shareholder of the Group, by virtue of his interest held through Hozone Sdn Bhd and does not hold any directorships in other public listed companies.

He is currently a Fellow of Malaysian Institute of Management and the Chairman of Malaysia Franchise Association for the period of 2017 -2021. Datuk Dr. Haji Radzali also sits as a member of the Franchise Licensing Board at the Ministry of Domestic Trade and Consumer Affairs and is a member of the Nexus Retail Board at the Malaysian Productive Council.

11

ADITYA CHATHLI

Non-Executive Director

Aditya Chathli was appointed as a Non-Executive Director of the Group on 29 September 2017 and chairs the Compliance Committee and is a member of the Audit, Nomination and Remuneration Committees.

He is an experienced capital markets expert with an approximately 27-year track record of advising global companies, organisations and government agencies. Currently Mr. Chathli is a Director of Luther Pendragon, one of the UK's leading independent communications consultancies, and a Director of a capital markets advisory consultancy, Access Capital Markets. He is also Chairman of Lokcom Networks Ltd, an IOT technology start-up company.

Over the past 20 years he has advised public companies listed on the London Stock Exchange's Main market and AIM as well as companies listed on NASDAQ and other international bourses. During this period, his extensive experience included advising on international M&A deals, IPOs, MBOs, crisis communications as well as financial PR starting in 1998 at Brunswick Group, a global partnership advising on business-critical issues to companies in 14 countries.

In 2004, Mr. Chathli established a financial PR company, Corfin, which was then acquired by Luther Pendragon in 2011.

TUAN SYED NAZIM SYED FAISAL

Executive Director

Tuan Syed Nazim Tuan Syed Faisal was appointed to the Board on 25 September 2018 to serve as Executive Director of the Group and is currently the Chief Executive Officer.

He is a highly experienced financial and strategic business planning professional with over 15 years of experience in the accounting and banking sectors. He holds a Degree in Accounting, Masters in Islamic Finance Practice and Certificate in Islamic Banking & Finance Law and is a MIA member since 2007.

Currently, Tuan Syed Nazim is the Non-Independent Executive Director of Serba Dinamik Holdings Berhad - a Malaysian-based investment holding company that manages the Serba Dinamik Group of international energy services companies including Serba Dinamik International Limited (SDIL).

Prior to joining Serba Dinamik, he held positions at Ibdar Bank in the Kingdom of Bahrain, RHB Islamic Bank in Malaysia and KPMG Malaysia. Tuan Syed Nazim is also a Director or Partner of the following companies or partnerships: CSE Global Limited, Fahrenheit Café Sdn Bhd, NAK Ventures Sdn Bhd, BIRR Capital Limited and PT Amorsk, Indonesia.

HABIZAN RAHMAN HABEEB RAHMAN

Executive Director

Habizan Rahman Habeeb Rahman was appointed to the Board on 30 April 2020 to serve as Executive Director of the Group. He is a Managing Partner of Messrs. Rahman Rohaida and Chief Legal & Regulatory at iFIBER Holdings Sdn Bhd.

He holds a LLB (Hons.) from the MARA University of Technology in 2004 and an Advanced Diploma in Syariah Law from the International Islamic University of Malaysia in 2009.

Mr. Habizan Rahman has been practising law since 2005, working at a number of Malaysian law firms, namely Messrs. Kadir Andri & Partners before establishing Messrs. Rahman Rohaida in 2011. His experience includes representing large construction companies and a major international oil & gas business in matters relating to commercial, banking, defamation, tort and corporate dispute resolution.

12

Directors' Report

The Directors have pleasure in submitting their report together with the audited consolidated financial statements for the year ended 31 December 2019.

The Company's registered office address is 12 Castle Street, St Helier, Jersey JE2 3RT, Channel Islands.

PRINCIPAL ACTIVITIES

The Company is principally an investment holding company, whilst its subsidiaries (together referred to as the "Group") are engaged in research and development, provision of professional engineering consultancy and process design services in the areas of industrial biotechnology, pollution control and renewable energy; and engineering, procurement and construction of various waste water treatment plants/systems; and the development, commercialisation, operation and maintenance of renewable energy power plants.

There have been no significant changes in the nature of these principal activities during the financial period.

FINANCIAL RESULTS

The financial results of the Group are set out in the Consolidated Statement of Comprehensive Income together with the accompanying notes to these statements.

In the opinion of the Directors, the results of the operation of the Group during the financial period have not been substantially affected by any item, transaction or event of a material and unusual nature, other than the one-off waiver of the amounts payable to previous Directors and other creditors. This had a positive impact on other income of RM6,329k.

DIVIDENDS

No dividend has been paid or declared since the date of incorporation of the Group and the Directors do not recommend the payment of dividends for the financial period ended 31 December 2019.

BUSINESS AND STRATEGIC REVIEW

The review of the Group's business operations, including key performance indicators, principal risks and uncertainties, research and development and future developments, are set out in the Chairman's Statement and the Operational and Financial Review on pages 4 - 10 together with this Directors' Report.

ADMISSION TO AIM

The Company was admitted to trading on AIM, a market operated by the London Stock Exchange plc, on 12 May 2016.

Further information relating to movements in the Company's share capital is set out in note 11 to the consolidated financial statements on page 56.

13

DIRECTORS

The Directors who served for the year ended 31 December 2019 (unless otherwise stated) are as follows:

• Datuk Dr. Haji Radzali Hassan
• Aditya Chathli
• Tuan Syed Nazim Syed Faisal
• Saravanan Rasaratnam (resigned on 31 January 2020,)
• Navindran Balakrishnan (resigned on 31 January 2020)

At each Annual General Meeting ("AGM") of the Company, as reflected in its Articles of Association, one third of the Directors who are subject to retirement by rotation shall retire from office and such Directors may stand for re-election subject to any rules of law to the contrary.

DIRECTORS' INTERESTS

According to the register of Directors' shareholdings, the interest of Directors, holding office at the end of the financial year, in the shares of the Company and related corporations during the financial year and as at the date of signing are as follows:

• On 1 November 2019, Saravanan Rasaratnam and Navindran Balakrishnan agreed to sell, subject to certain conditions, their entire share holdings in K2M Ventures Sdn Bhd to Habizan Rahman Habeeb Rahman, the Executive Director appointed on 30 April 2020.

DIRECTORS' REMUNERATION

The Directors' remuneration is set out in the Remuneration Report. In addition, the Directors' and Officers' insurance policy cover has been put in place to indemnify the Directors and Officers against any legal action by third parties.

14

SUBSTANTIAL SHAREHOLDERS

Based on the register of people with significant control (Aim 17) as at 1 January 2020, individual registered shareholdings of more than 3% of the Company's issued capital were as follows:

• As at 1 January 2020 Saravanan Rasaratnam and Navindran Balakrishnan, each of whom were Directors of the Company, each owned 50% of the entire issued share capital of K2M Ventures Sdn Bhd (K2MV). They also held interests in the Company's shares in their own names (see note below).
• These shares were held by each of Saravanan Rasaratnam and Navindran Balakrishnan, each of whom were Directors of the Company, in their own names. In addition, as set out above, Saravanan Rasaratnam and Navindran Balakrishnan at the time each owned 50% of the entire issued share capital of K2MV, the registered holder and owner of 112,319,753 shares.

RESEARCH AND DEVELOPMENT

With an operating subsidiary (BiON Sdn Bhd) having been conferred the BioNexus Status by a governmental industry development agency known as Malaysian Bioeconomy Development Corporation Sdn Bhd, the Group continues to invest in research and development ("R&D") on its three existing in-house developed Intellectual Properties.

The Group has a policy of expensing R&D costs through the Consolidated Statement of Comprehensive Income. In addition, the Group is committed to offer opportunities to its existing employees in training, career development and advancement with the Group.

RISKS RELATING TO THE GROUP AND ITS BUSINESS

Market Risks

The Group may be affected by general market trends that are both related and unrelated to the performance of the Group and to the entry of more competitive players and bids, usurping the Group's current unique selling proposition. The success of the Group is dependent on the market acceptance and recognition of its brand, products and services, of which there can be no guarantee. Present opportunities targeted by the Group may change with a negative consequence on earnings and revenue. The Group continuously monitors its competitive landscape and continues to invest in R&D activities as a measure of mitigating market uncertainties.

Technological Evolution

The industry the Group is in requires continuous research and development and there is no denying that the Group's business and prospects may be impacted by continual technology evolution, introduction of new products, changing industry standards and customers' needs and expectations. Thus, ongoing R&D and the continued emphasis on training of existing personnel, enhancing their know-how and technical capability is critical to the Group's continued growth and expansion.

15

Dependence on Key Executives and Technical Personnel

The Group's business is dependent on attracting and retaining its key executives in management and R&D. Despite the Group having entered into contractual arrangements to secure the services of these senior and key personnel, the retention of these personnel cannot be guaranteed. Failure to retain and attract the services of these personnel may adversely affect the business and growth prospects of the Group.

Competition Risk

The Group operates in a competitive market. These competitors may have existing or more advanced technology and services that compete with the products and services offered by the Group. Such competition may adversely affect the Group's business and prospects. Hence, it is essential the Group continues to maintain its competitive edge through continuous R&D.

Protection of Intellectual Property

The Group has Intellectual Properties and trademarks and whilst Management believe that the Group's efforts to protect its intellectual property rights are adequate, there is no guarantee. There is always the risk of misappropriation of the Group's intellectual property or unauthorised use of its intellectual property rights.

Reliance on Key Systems

The Group's reliance on certain key systems and technologies for its continuous operation exposes the Group to significant risk to damage or interruption to these systems despite proper control and safeguards in place. Many eventualities could be anticipated but there are those beyond the Group's ability to predict, the occurrence of which could have significant detrimental consequences to the Group's operations and business.

Foreign Currency Risk

Although the Group's principal operations are in Malaysia and the bulk of its exposure is in Ringgit, the Group is nevertheless exposed to foreign exchange fluctuations as some of its vendors are overseas. Fluctuations in exchange rates may have a material adverse effect on the Group's profitability. There can be no guarantee that the Group would be able to compensate or hedge against such effects and this could have an adverse effect on the Group's prospects and performance.

Political, Economic and Regulatory Risks

The Group may be affected by adverse developments in the political, economic and regulatory environment in which the Group operates, which could be the result of a global pandemic such as COVID-19. A prolonged economic downturn or the inability to operate plants and equipment due to lockdowns to protect public health may lead to an overall decline in sales and profitability. Although adequate provisions are in place to protect against such uncertainties, there is no assurance that these events will not adversely affect the Group.

GOING CONCERN

The Directors, having considered "Going Concern and Liquidity Risk: Guidance for Directors of UK Companies" issued by The Financial Reporting Council in 2016, consider the going concern basis of preparation to be appropriate in preparing the financial statements. The key conclusions are summarised below.

The Group made a loss for the period of RM0.07m (2018: RM13.66m) and recorded a net cash inflow from

operating activities of RM0.38m (2018: outflow of RM12.08m). At the reporting date the Group held cash and cash

equivalents of RM0.08m (2018: RM0.47m) and had current liabilities of RM69.91m (2018: RM40.18m).

As described in note 7, amounts of RM10.51m (2018: RM17.91m) are due to the Group from Concord Green Energy Sdn Bhd ("CGE"). A repayment plan was put in place during the year and RM7.40m was repaid. Due to the repayment plan not being upheld subsequent discussions are taking place to re-negotiate the terms of

16

repayment and in the meantime, Serba Dinamik Sdn. Bhd. and one of the executive directors, have guaranteed the value of the debt.

As described in note 8, amounts of RM63.35m (2018: RM38.33m) are due to the Group from Megagreen Energy

Sdn Bhd ("MGE"). Further debts arose during the financial period of approximately RM25.02m (2018: RM1.27m) from MGE. The repayment arrangement put in place during the year recovered RM3.13m. As a result of renegotiations taking place to acquire two (2) biogas power plants located in Perak, in part exchange for some of the receivables this repayment arrangement was put on hold. These acquisitions completed in Q3 2020 and further negotiations are taking place to acquire an additional three (3) biogas power plants and is expected to be finalised upon satisfactory outcome from the due diligence exercise.

The Directors consider the amounts owing to be recoverable in full as a result of negotiations being undertaken.

The Group has also received a letter of support from one of its largest shareholders, Serba Dinamik Sdn. Bhd. giving its willingness to continue to fund the Group.

COVID-19 has been identified as having a significant impact on the Group in the 2020 financial year due to public lockdown. However, as restrictions have been eased and activity is increasingly resuming, the Directors continue to believe that the Group remains viable for the foreseeable future.

The Directors prepared financial projections and plans for a period of at least 12 months from the date of approval of these financial statements. On assessment of the Group's future cash flows, the new financing arrangements that have been made available from the SME Bank loan (detail in note 36), as well as the agreed letter of support from Serba Dinamik Sdn. Bhd. and an assessment of their willingness to perform under this the Directors believe the Group has the ability to continue as a going concern for at least 12 months.

ANNUAL GENERAL MEETING

The notice for convening of the Annual General Meeting ("AGM") by the Company is disseminated together with the proposed resolutions and contained in the Notice of AGM.

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The Directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations. Company law requires the Directors to prepare Group financial statements for each financial period/year.

Under Company Law, the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Group and of the profit or loss of the Group for that period.

In preparing the Group financial statements, the Directors are required to:

• select suitable accounting policies and then apply them consistently;
• make judgements and accounting estimates that are reasonable and prudent;
• state whether they have been prepared in accordance with International Financial Reporting Standards (IFRSs) adopted by the European Union (EU) and the provision with the Companies (Jersey) Law 1991; and
• prepare financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.

The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Group's transactions and disclose with reasonable accuracy at any time the financial position of the Group and enable them to ensure that the financial statements comply with the Companies (Jersey) Law 1991. They are also responsible for safeguarding the assets of the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

17

Website Publication

The Directors are responsible for ensuring that the Directors' report and other information included in the Annual Report and the financial statements are made in accordance with applicable law. The maintenance and integrity of the BiON plc website is the responsibility of the Directors; work carried out by the auditors does not involve the consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred in the accounts since they were initially presented on the website.

Legislation in Jersey governing the preparation and dissemination of financial statement may differ from legislation in other jurisdictions.

AUDITOR AND DISCLOSURE OF INFORMATION TO AUDITOR

The Directors who held office on the date of approval of this Directors' Report confirm that, so far as they are aware, there is no relevant audit information of which the Company's auditor is unaware. The Directors have confirmed that they have taken all steps that they ought to have taken as Directors in order to make themselves aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Haysmacintyre LLP was appointed auditor of the Company at the AGM held on 25 October 2018. Haysmacintyre LLP have indicated their willingness to be reappointed as statutory auditor. A resolution for the reappointment of Haysmacintyre LLP as auditor of the Company is to be proposed at the forthcoming Annual General Meeting.

This report was approved by the Board and signed on its behalf.

By order of the Board of Directors,

Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah

Non-Executive Chairman

30 September 2020

18

Corporate Governance Report

The Directors of BiON plc recognise the importance of high standards of good corporate governance and have chosen to adopt the Quoted Companies Alliance Corporate Governance Code (the "QCA Code"), in line with the London Stock Exchange's recent changes to the AIM Rules requiring all AIM-listed companies to adopt and comply with a recognised corporate governance code, as the basis of the Company's governance framework.

The Board believes that good corporate governance reduces risks within the business, promotes confidence and trust amongst its stakeholders and is an important part of the effectiveness and efficiency of the Company's management framework. The Board considers that the Company complies with the QCA Code so far as is practicable having regard to the size, nature and current stage of the Company's development. The Company will provide annual updates on its compliance with the QCA Code.

The QCA Code includes ten (10) broad principles that the Company strives to ensure that it has the appropriate corporate governance arrangements implemented with the aim of delivering growth to its shareholders in the medium and long-term.

COMPANY'S APPLICATION OF THE QCA CODE

The Company's application of the ten (10) principles of the QCA Code are set below:

Principle 1:

Establish a strategy and business model which promote long-term value for shareholders

• The Company reiterates its strategy through its announcements and presentations to investors, particularly at the time of its financial results, which is to grow the Company as a waste-to-energy solutions provider and an independent power producer (IPP) through building, owning and operating biogas power plants in close proximity to palm oil mills in Malaysia and generating revenue from the sale of electricity to the national grid under the 21-year FiT mechanism.
• To secure its long-term growth, the Company is an active bidder in the FiT quota system. The Company also provides EPCC and operations & maintenance ("O&M") services to owners of other biogas power plants in the country.
• The Board recognises the key challenges to the business, which are detailed on pages 15-16 of the Company's Annual Report and Accounts for the year ended 31 December 2019.

Principle 2:

Seek to understand and meet shareholder needs and expectations

• To ensure its strategy, operational results and financial performance are clearly understood, the Board is committed to engaging and updating its shareholders through its regulatory announcements and practices two-way communication with both its institutional and private investors and responds to queries received.
• The Board believes that the shareholder expectations are managed through its regulatory disclosures and the AGM, which all Board members endeavor to attend either in person or tele-conference call.
• The Executive Directors and Non-Executive Directors talk regularly with the Company's major shareholders and ensure that their views are communicated fully to the Board.
• The Board members make themselves available to meet with shareholders and potential investors as and when required.
• The Independent non-executive director is UK-based and makes himself available to meet with shareholders as requested.

19

Principle 3:

Take into account wider stakeholder and social responsibilities and their implications for long-term success

• The Company recognises the importance of engagement with its stakeholder groups, which, in addition to investors, include its employees, clients, vendors, local communities and the relevant authorities.
• By the nature of its business, with the biogas power plant built on or in close proximity to the site of palm oil mills, the Company maintains close relations with its clients and vendors. The Company ensures that regular dialogues are held with these parties and the relevant authorities.
• The Company endeavours to take account of feedback received from these stakeholders, thereafter, revising and improvising its working arrangements and operational plans accordingly, where appropriate and where such amendments are consistent with the Company's long-term strategy.
• Environmental responsibility and sustainability are fundamental to the Company, having spent over 35 years providing waste treatment solutions to minimise the environmental impact of industrial processes before transitioning to treat POME. As a result, the Company now mitigates the impact of the palm oil industry by rendering the effluent harmless to the environment and converting the by-product of the treated waste into renewable energy.
• The Company is also mindful of its broader corporate and social responsibilities. In particular, the Company supports the local communities on the palm oil plantations where it operates by giving priority to local residents in the vicinity and their kin when seeking employees to work at its biogas power plants.
• The Company engages with its employees through regular gatherings organised by the Human Resources Department, which provide an opportunity for employees to interact with the Management and informally address any concerns or issues.

Principle 4:

Embed effective risk management, considering both opportunities and threats, throughout the organisation

• The Company's Annual Report and Accounts for the year ended 31 December 2019 details the key risks to the business on page 15 - 16 and the Company's internal control measures are detailed on page 25.
• The Company has an established framework of internal controls, the effectiveness of which is regularly reviewed by the Senior Management, the Audit Committee and the Board.

Principle 5:

Maintain the board as a well-functioning, balanced team led by the chair

• The composition, roles and responsibilities of the Board and its Committees are set out on pages 22 - 24 of the Annual Report and Accounts for the year ended 31 December 2019. The number of meetings of the Board and
  Directors' attendance is also detailed.
• To enable the Board to discharge its duties, all Directors receive appropriate and timely information. Briefing papers are distributed to all Directors in advance of the Board and Committee meetings. All meetings are minuted accordingly and approved by the Chair before circulation to all Board members.
• The composition of the Board is outlined on pages 22 - 24 of the Annual Report and Accounts for the year ended 31 December 2019. The Board considers Datuk Dr. Haji Radzali Hassan and Aditya Chathli to be independent.
• Post year-end, as of 31 January 2020, Saravanan Rasaratnam and Navindran Balakrishnan stepped down as Executive Directors and resigned from all positions within the Company.
• Subsequently, on 30 April 2020, Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah and Habizan Rahman Habeeb
  Rahman were appointed as Non-Executive Chairman and Executive Director, respectively. Datuk Dr. Haji Radzali Hassan, the former Chairman remained on the Board and assumed the role of Senior Independent Non-Executive Director of the Company in view of his vast business experience and having served as Non- Executive Chairman for the past four (4) years.
• As at today, the Board comprises of the following members:
• • Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah - Non-Executive Chairman
  • Datuk Dr. Haji Radzali Hassan - Senior Independent Non-Executive Director
  • Aditya Chathli - Non-Executive Director
  • Tuan Syed Nazim Syed Faisal - Executive Director
  • Habizan Rahman Habeeb Rahman - Executive Director

20

Principle 9:

Maintain governance structures and processes that are fit for purpose and support good decision-making by the board

• The Corporate Governance Statement on pages 19 - 22 of the Annual Report and Accounts for the year ended 31 December 2019 details the corporate governance structures and processes for the company.
• This is in relation to the separation of powers of the Executive Board, the institution of respective Board Committees with clear demarcated roles and responsibilities including planned meetings and reporting.

Principle 10:

Communicate how the Company is governed and is performing by maintaining a dialogue with shareholders and other relevant stakeholders

• Pertinent information is disseminated and communicated by the Company to its shareholders through the Annual Report and Accounts, full-year and half-year results announcements, operational announcements and the AGM. Corporate information is also made available to shareholders, investors and the public on the
  Company's corporate website: www.bionplc.com.
• The Company has announced the detailed results of shareholder voting to the market previously and will continue to do so. The Board will also disclose any actions to be taken as a result of resolutions for which votes against have been received from at least 20% of independent shareholders.

BOARD OF DIRECTORS AND BOARD COMMITTEES

The Board is responsible for formulating, reviewing and approving the Group's strategy, budgets and corporate actions. The Board is also responsible for ensuring a healthy corporate culture. Based on the nature of its business and the stage of the Group's development, this is largely implemented informally through interaction with employees and the approach to recruitment, with the Directors promoting a transparent, flexible and open culture in recognition that this will best serve the Group's strategy.

The Board consisted of three Executive Directors and two Non-Executive Directors during the year ended 31 December 2019.

The Executive Directors were Tuan Syed Nazim Syed Faisal, Saravanan Rasaratnam and Navindran Balakrishnan.

The Non-Executive Directors comprised of an Independent Non-Executive Chairman, Datuk Dr. Haji Radzali Hassan and an Independent Non-Executive Director, Aditya Chathli.

Post year-end, as of 31 January 2020, Saravanan Rasaratnam and Navindran Balakrishnan stepped down as Executive Directors and resigned from all positions within the Company.

Subsequently, on 30 April 2020, Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah and Habizan Rahman Habeeb Rahman were appointed as Non-Executive Chairman and Executive Director, respectively. Datuk Dr. Haji Radzali Hassan, the former Chairman remained on the Board and assumed the role of Senior Independent Non- Executive Director of the Company.

The Board met on three occasions during the year to 31 December 2019.

22

The table below sets out the Board meetings as well as the Audit Committee meetings respectively held by the Company for the financial year ended 31 December 2019 and attendance of each Director:

The Board has established four Committees with clearly defined terms of reference and detailed below are the members of the Committees and their duties and responsibilities.

Audit Committee

The Audit Committee has primary responsibility for monitoring the quality of internal controls and ensuring that the financial performance of the Group is properly measured and reported on. It receives, and reviews reports from the Group's management and auditors relating to the interim and annual accounts and the accounting and internal control systems in use throughout the Group.

For the year ended 31 December 2019, the Audit Committee was chaired by Datuk Dr. Haji Radzali Hassan and its other member, Aditya Chathli.

On 30 April 2020, Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah was appointed as Non-Executive Chairman of the Company and a member of the Audit Committee.

For the year under review, three Audit Committee meetings were held, and all members of the committee were in attendance. During the year, the Audit Committee reviewed and approved the interim and full year results and annual accounts. A copy of the Audit Committee's report is included herein on Pages 26 - 27.

Remuneration Committee

The Remuneration Committee reviews the performance of the Executive Directors and makes recommendations to the Board on matters relating to their remuneration packages and terms of employment.

The Committee also makes recommendations to the Board on proposals for the granting of share options and other equity incentives pursuant to any share option scheme or equity incentive scheme in operation from time to time. No Director may be involved in any discussions as to his own remuneration.

For the year ended 31 December 2019, the Remuneration Committee was chaired by Datuk Dr. Haji Radzali Hassan and its other member, Aditya Chathli.

On 30 April 2020, Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah was appointed as Non-Executive Chairman of the Company and a member of the Remuneration Committee.

For the year under review, one Remuneration Committee meeting was held and all members of the committee were in attendance. During the period, the Remuneration Committee determined and proposed to the Board to maintain the Directors' current annual fees. A copy of the Remuneration Committee's report is included herein on Pages 28 - 29.

23

AIM Compliance Committee

The AIM Rules Compliance Committee ensures that procedures, resources and controls are in place to ensure AIM Rules compliance by the Group is operating effectively at all times and that the Executive Directors are communicating as necessary with the Company's Nominated Advisor regarding ongoing compliance with the AIM Rules for Companies, in particular Rules 11, 17, 18 and 19, including without limitation in relation to all announcements and notifications and proposed or potential transactions.

The AIM Compliance Committee works closely with the Board to ensure that the Group's nominated adviser is provided with any information it reasonably requests or requires in order for it to carry out its responsibilities under the AIM Rules for Companies and the AIM Rules for Nominated Advisers.

For the year ended 31 December 2019, the AIM Compliance Committee was chaired by Aditya Chathli and its other member was Datuk Dr. Haji Radzali Hassan.

On 30 April 2020, Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah was appointed as Non-Executive Chairman of the Company and a member of the AIM Compliance Committee.

For the year under review, one AIM Compliance Committee meeting was held, and all members of the committee were in attendance. The AIM Compliance Committee noted that the Company adheres to the corporate governance reporting requirements and AIM Rules i.e. publication of the Annual Report, announcements, the QCA Code and Investor Relations sections of the corporate website - all of which are up to date.

Nomination Committee

The Nomination Committee is responsible for identifying and nominating Directors and recommending Directors to be appointed to each Committee of the Board and the Chair of each such Committee. The Committee also arranges for evaluation of the Directors.

For the year ended 31 December 2019, the Nomination Committee was chaired by Datuk Dr. Haji Radzali Hassan and its other member, Aditya Chathli.

On 30 April 2020, Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah was appointed as Non-Executive Chairman of the Company and Chairman of the Nomination Committee, whilst Datuk Dr. Haji Radzali Hassan continues to serve as Senior Independent Non-Executive Director of the Company and member of the Nomination Committee.

For the period under review, one Nomination Committee meeting was held and all members of the committee were in attendance. The Nomination Committee reviewed the service contracts of Directors, whose term of service had expired, and recommended to the Board for Directors to continue remaining in service. The Nomination Committee recommended to the Board the nomination of Dato' Dr. Ir. Ts. Mohd Abdul Karim Abdullah as a Non- Executive Director of the Company.

INVESTOR RELATIONS

Meetings with analysts and institutional shareholders of the Group following interim and annual results announcements and on an as-needed basis are attended by members of the Board to update the shareholders on the progress of the Group in terms of its business, financial performance and strategic direction.

Post year-end and in view of the Covid-19 pandemic, the Company is considering the possibility of future meetings with analysts and institutional shareholders via online video conferencing.

The Annual Report and accounts are published on the Group's website, www.bionplc.com and can be accessed by shareholders.

24

INTERNAL CONTROL AND RISK MANAGEMENT

The Board is responsible for the Group's internal control systems and for reviewing the effectiveness of the systems. The systems can only provide reasonable but not absolute assurance against material misstatements or losses as the systems are put in place to manage and minimise the risks but not to eliminate them.

With the active involvement of the Executive Directors in the daily operations and management of the Group through regular meetings with staff, business risks are identified, and appropriate control systems implemented to manage the risks. The effectiveness of the control systems is reviewed and updated periodically by the Corporate Office and adopted by the respective Principal Office, as and when it is appropriate.

The Group's internal financial control procedures and monitoring systems include the following:

• Financial policies and approval procedures with proper authorisation level and segregation of duties for financial management;
• Maintenance policies and approval procedures with proper authorisation level and segregation of duties for financial management;
• An annual budgetary process to set the appropriate target for monitoring the progress of the Group;
• A detailed monthly financial reporting system that reports on operating results, cash flows, assets and liabilities with comparisons against budgets;
• Reporting on any non-compliance with internal financial controls and procedures; and
• Review of the audit findings report issued by the external auditor.

The Audit Committee on behalf of the Board reviews reports from the external auditor together with Management's response regarding proposed actions. The Group is bound by the Corruption (Jersey) Law 2006 (as amended), in respect of its conduct in Jersey and elsewhere, and the Group will observe the provisions of the UK Bribery Act 2010 and other laws relating to anti-corruption in other jurisdictions in which it operates.

The Board has adopted an anti-bribery and corruption policy to implement the Group's commitment to carrying on its business fairly, openly and honestly and to prevent bribery and corruption by persons associated with the Group.

25

Audit Committee Report

Dear Shareholders

On behalf of the Board, I am pleased to present the Audit Committee report for the financial year ended 31 December 2019.

PRINCIPLE RESPONSIBILITIES OF THE COMMITTEE

• Ensuring the financial performance of the Group is properly reviewed, measured and reported;
• Monitoring the quality and adequacy of internal controls and internal control systems implemented across the Group;
• Receive and review reports from the Group's management and auditors relating to the interim and annual accounts;
• Reviewing risk management policies and systems;
• Advising on the appointment, re-appointment and remuneration of independent external auditors, besides scheduling meetings with external auditors independent of management for discussions and reviews; and
• Reviewing and monitoring the extent and independence of non-audit services rendered by external auditors.

MEMBERS OF THE COMMITTEE

During the reporting period, the Committee consisted of two Independent Non-Executive Directors, namely Datuk Dr. Haji Radzali Hassan (Chair) and Aditya Chathli.

The Committee met three times during the year.

AUDIT PROCESS

The audit process commences with the auditors preparing an audit plan which contains information pertaining to the due audit process, timetables, targeted areas and general scope of work. A pre-audit meeting is then scheduled with the Audit Committee for discussions and endorsement of the audit plan and to consider any pertinent matters or areas for special inclusion.

Following the audit, an Audit Findings Report is prepared by the auditors and furnished to the Audit Committee followed by a second meeting with the Audit Committee to review and discuss its contents. The Audit Committee will furnish a report to the Board together with its recommendations.

For the financial year ended 31 December 2019, no major areas of concern were highlighted, and the Board will undertake all necessary corrective measures as recommended.

INTERNAL AUDIT

At present, the Group does not have an internal audit function and the Committee believes that despite this, management is able to derive assurances as to the adequacy and effectiveness of internal controls and risk management procedures.

26

RISK MANAGEMENT AND INTERNAL CONTROLS

As disclosed on page 25 per the Corporate Governance Report in the 2019 Annual Report, the Group has established a framework of risk management and internal control systems, policies and procedures. The Audit Committee is responsible for reviewing the risk management and internal control framework and ensuring its effectiveness.

As further noted, the Board has adopted an anti-bribery and corruption policy in its commitment to carrying on its business fairly, openly and honestly and to prevent bribery and corruption by persons associated with the Group and these policies are continuously reviewed by the Audit Committee.

During the reporting period, the Committee has reviewed and recommended measures to further strengthen these policies and are satisfied that the framework is operating effectively.

Datuk Haji Radzali Bin Hassan

Senior Independent Non-Executive Director & Audit Committee Chair

30 September 2020

27

Remuneration Committee Report

REMUNERATION COMMITTEE

During the reporting period, the Remuneration Committee consisted of two Independent Non-Executive Directors, namely Datuk Dr. Haji Radzali Hassan (Chair) and Aditya Chathli.

The terms of reference of the Committee are reviewed periodically by the Board. The Remuneration Committee is responsible for determining the Group's policy on the remuneration of Senior Executives and specific remuneration packages for Executive Directors, including pension rights and compensation payments.

For the period under review, one Remuneration Committee meeting was held, and all members of the committee were in attendance. During the year, in particular, the Remuneration Committee reviewed the Directors' annual fees and proposed to the Board that it be maintained to conserve the cashflow of the Company. This proposal was accepted by the Board and is being implemented for the current year.

REMUNERATION POLICY

The objective of the proposed Remuneration Policy is to attract, retain and motivate high calibre executives to deliver outstanding shareholder returns and at the same time maintain an appropriate compensation balance with the other employees of the Group.

DIRECTORS' REMUNERATION

The normal remuneration arrangements for Executive Directors consists of base salary, performance bonuses and other benefits as determined by the Board. Each of the Executive Directors has a service agreement that can be terminated at any time by either party giving to the other six months' written notice. Compensation for loss of office is restricted to base salary and benefits only.

The remuneration packages for the Executive Directors are detailed below:

• Base Salary:
  Annual review of the base salaries of the Executive Directors are concluded after taking into account the
  Executive Directors' role, responsibilities and contribution to the Group performance.
• Performance Bonus:
  Bonus arrangements are discretionary and are payable depending on the performance of the Executive Directors in meeting their key performance indicators and in the wider context with the performance of the Group.
• Benefits:
  Benefits include payments for provident funds that are mandatory and statutory pension payments as required by laws of the resident countries of the Executive Directors, health insurance and other benefits.

Non-Executive Directors are remunerated solely in the form of Director Fees, as determined by the Board and are not entitled to pensions, annual bonuses or employee benefits. Each of the Non-Executive Directors has entered into a service agreement for an initial term of two years and stating his annual fee and that the appointments are to continue unless terminated by either party giving to the other six months' written notice.

The Directors are not involved in specific discussions on their own remuneration.

28

DIRECTORS' REMUNERATION AND FEES

The tables below set out the respective Directors' remuneration and fees:

• Directors remuneration and related cost were being paid via its Group's subsidiary, BiON Ventures Sdn Bhd and whereas the directors fees were being paid via BiON plc.

Datuk Haji Radzali Bin Hassan

Senior Independent Non-Executive Director & Remuneration Committee Chair

30 September 2020

29

Independent Auditor's Report

Opinion

We have audited the financial statements of BiON plc (formerly Green & Smart Holdings Plc) ("the Company") and its subsidiary undertakings (together "the Group") for the year ended 31 December 2019, which comprise:

• the Consolidated Statement of Financial Position;
• the Consolidated Statement of Comprehensive Income;
• the Consolidated Statements of Changes in Equity;
• the Consolidated Statements of Cash Flows; and
• the notes to the Consolidated Financial Statements, including a summary of significant accounting policies.

The financial reporting framework that has been applied in the preparation of the financial statements is applicable law and International Financial Reporting Standards ("IFRSs") as adopted by the European Union ("EU").

In our opinion, the financial statements:

• give a true and fair view of the state of the Group's affairs as at 31 December 2019 and of the Group's loss for the year then ended;
• have been properly prepared in accordance with IFRSs as adopted by the EU; and
• have been prepared in accordance with the requirements of the Companies (Jersey) Law 1991.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the Financial Reporting Council's (FRC) Ethical Standard as applied to listed entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

• the Directors' use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or
• the Directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about Group's ability to continue to adopt the going concern basis of accounting for a period of at least 12 months from the date when the financial statements are authorised for issue.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current period and include the most significant assessed risks of material misstatement (whether or not due to fraud) we identified, including those which had the greatest effect on: the overall audit strategy; the allocation of resources in the audit; and directing the efforts of the engagement team.

These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

30

Key audit matter: Going concern

There is a risk that the Group may not be a going concern. The decrease in cash compared to the prior year and the net current asset positions are potential indicators of risks that the Group is not a going concern. Continued support is likely to be required to support investing activities.

Subsequent to the year-end,COVID-19 was declared a pandemic by the World Health Organisation and as detailed in note 2 and in the Chief Executive Officer's Review on page 7, this had a significant impact on the Group's ability to operate, giving rise to a further indicator of a risk that the Group may not be a going concern.

Furthermore, as discussed in the 'Key audit matter: Recoverability of receivables' section below, the risk that receivables are not recoverable, is a further indicator of a risk to the Group's status as a going concern.

How the matter was addressed in the audit

Our audit work included, but was not restricted to:

• reviewing and assessing the component auditor's work regarding the going concern assumption of each subsidiary;
• reviewing the Group's cash flow forecasts and budgets for a minimum period of 12 months post signing the financial statements;
• assessing the reasonableness of assumptions applied to the cash flow forecasts;
• reviewing post-period end management financial information;
• performing sensitivity analysis on the forecasts;
• discussing future plans, future revenue streams and pipeline projects with management;
• reviewing and assessing the reasonableness of the continued financial support provided by Serba Dinamik Sdn Bhd and executive directors of the Company;
• incorporating our testing around the recoverability of receivables into the going concern review; and
• reviewing loan facilities which were approved by the bank post year-end.

Key audit matter: Recoverability of receivables

There is a risk that certain trade and other receivables are not recoverable and therefore are materially overstated. There has been evidence of slow payment historically.

How the matter was addressed in the audit

Our audit work included, but was not restricted to:

• reviewing component auditors' work around the recoverability of receivables from related entities (or historically related entities);
• obtaining confirmations of receivables balances through a receivables circularisation;
• reviewing post year-end recovery of receivables, including specifically reviewing the post year-end transfer of assets (and further proposed transfers) to the Group, as payment against specific receivables;
• reviewing guarantees made in relation to the recovery of receivable balances;
• reviewing correspondence with companies with old receivables; and
• discussing historic balances with management to understand reasons for delayed payments.

Key observations

Without qualifying our opinion, we draw attention to notes 7 and 8 to the financial statements relating to the recoverability of the related party receivables and trade receivables past due by more than 6 months totaling RM15,966k and RM30,958k respectively. The Directors are of the opinion that the receivables are recoverable and no additional allowance for doubtful debts is required as at 31 December 2019.

31

Key audit matter: Revenue recognition

Under International Standards on Auditing (UK) 240 'The Auditors' Responsibilities Relating to Fraud in an Audit of Financial Statements there is a rebuttable presumed risk that revenue may be misstated due to the improper recognition of revenue.

We therefore identified revenue recognition as a significant risk of material misstatement.

How the matter was addressed in the audit

Our audit work included, but was not restricted to:

• reviewing component auditors' work around the recognition of revenue in accordance with Malaysian Financial Reporting Standards 15 ('MFRS15') which is materially the same as 'IFRS 15 Revenue from contracts with customers';
• considering the stated accounting policies in respect of revenue recognition and whether these are consistent with IFRS 15 Revenue from contracts with customers;
• testing that the stated accounting policies had been applied accurately and consistently;
• testing a sample of sales transactions recorded either side of the balance sheet date for correct application of cut-off;
• substantively testing a sample of sales transactions during the year ended 31 December 2019, ensuring that the significant risks and rewards had been passed to the customer on recognition of revenue; and
• completing analytical review of revenue recognised in the year.

The Group's accounting policy on revenue recognition is shown in note 4.10 to the financial statements.

Key audit matter: Potential impairment of fixed assets

There is a risk that fixed assets are materially overstated and therefore require impairment.

How the matter was addressed in the audit

Our audit work included, but was not restricted to:

• reviewing and assessing component auditors' work around the impairment reviews of fixed assets;
• reviewing and assessing cashflow forecasts against significant fixed assets for evidence of impairments;
• recalculating the NPV of assets based on management's assumptions, whilst scrutinising such assumptions; and
• discussing impairment reviews with management.

Overview of our audit approach

Materiality

The scope and focus of our audit was influenced by our assessment and application of materiality. We define materiality as the magnitude of misstatement that could reasonably be expected to influence the readers and the economic decisions of the users of the financial statements. We use materiality to determine the scope of our audit and the nature, timing and extent of our audit procedures and to evaluate the effect of misstatements, both individually and on the financial statements as a whole.

Based on our professional judgement, we determined overall materiality for the Group financial statements as a whole at the planning stage to be RM790,000, based on 0.8% of the Group's gross assets in the prior year. The principal focus of stakeholders is considered to be asset focused; our planning materiality equates to 0.6% of final gross assets and we therefore maintained our planning materiality throughout audit testing and completion.

We use a different level of materiality ('performance materiality') to determine the extent of our testing for the audit of the financial statements. Performance materiality is set based on 75% of audit materiality, rounded down to the nearest RM5,000, being RM590,000.

32

We agreed with the Audit Committee to report to it all identified errors in excess of RM40,000. Errors below that threshold would also be reported to it if, in our opinion as auditor, disclosure was required on qualitative grounds.

Other information

The Directors are responsible for the other information. The other information comprises the information included in the Annual Report, other than the financial statements and our auditor's report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Responsibilities of the Directors for the financial statements

As explained more fully in the Directors' responsibilities statement set out on page 17, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the Directors are responsible for assessing the Group's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Directors either intend to liquidate the Group or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

33

Use of our report

This report is made solely to the Company's members, as a body, in accordance with Article 113A of the Companies (Jersey) Law 1991. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Jon Dawson (Senior Statutory Auditor) for and on behalf of

Haysmacintyre LLP

Statutory Auditor

10 Queen Street Place

London

EC4R 1AG

30 September 2020

34

BiON plc (Formerly known as Green & Smart Holdings plc)

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at

The notes to the financial statements form an integral part of these financial statements.

The financial statements were approved by the Board of Directors and authorised for issue on 30 September

2020 and were signed on its behalf by:

Syed Nazim Syed Faisal

35

BiON plc (Formerly known as Green & Smart Holdings plc)

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the

The notes to the financial statements form an integral part of these financial statements.

All amounts are derived from continuing operations.

36

BiON plc (Formerly known as Green & Smart Holdings plc)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

The notes to the financial statements form an integral part of these financial statements.

• The issue of shares is recognised net of fundraising cost totaling to RM Nil.
• Details explained in note 3 (iv), changes in accounting policies.

37

BiON plc (Formerly known as Green & Smart Holdings plc)

CONSOLIDATED STATEMENT OF CASH FLOW

For the

The notes to the financial statements form an integral part of these financial statements.

38

BiON plc (Formerly known as Green & Smart Holdings plc)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2019

1. GENERAL INFORMATION

BiON plc (formerly known as Green & Smart Holdings plc) ("the Company") was incorporated as a public limited company in Jersey with registration number 119200 on 7 August 2015. The registered office of the Company is 12 Castle Street, St. Helier, Jersey JE2 3RT, Channel Islands.

Pursuant to a special resolution ratified at the Extraordinary General Meeting of the Company held on 30 April 2020, the Company has changed its name to BiON plc. Accordingly the change of name was taken effective from 1 May 2020, upon receiving the certificate from the Registrar of Companies in Jersey.

The Company is listed on the AIM market of the London Stock Exchange. The Company's nature of operations is to act as the holding company for a group of subsidiaries that are involved in research and development, provision of professional engineering consultancy and process design services in the areas of industrial biotechnology, pollution control and renewable energy; and engineering, procurement and construction of various waste treatment plants/systems; development, commercialisation, operation and maintenance of renewable energy plants.

The consolidated financial statements include the financial statements of the Company and its controlled subsidiaries (the "Group") as follows:

Note 1 - registered address: B-1-15, Block B, 8 Avenue, Jalan Sungai Jernih 8/1, Section 8, 46050 Petaling Jaya, Selangor.

Note 2 - registered address: 3-2, 3rd. Mile Square, No. 151, Jalan Klang Lama, Batu 3 ½, 58100 Kuala Lumpur.

2. BASIS OF PREPARATION

The financial statements have been prepared in accordance with International Financial Reporting

Standards as adopted by the EU ("IFRS") issued by the International Accounting Standards Board

("IASB"), including related interpretations issued by the International Financial Reporting

Interpretations Committee ("IFRIC").

As permitted by Companies (Jersey) Law 1991 only the consolidated financial statements are presented.

39

The financial statements are presented in Ringgit Malaysia ("RM") unless otherwise stated and is the currency of the primary economic environment in which the Group operates. All values are rounded to the nearest thousand ringgits ("RM'000") except where otherwise indicated.

The results for 31 December 2019 are prepared for a 12-month period and therefore the comparative amounts, 15-month period to 31 December 2018, are not entirely comparable.

GOING CONCERN

The financial statements are required to be prepared on the going concern basis unless it is inappropriate to do so.

The Directors, having considered "Going Concern and Liquidity Risk: Guidance for Directors of UK Companies" issued by The Financial Reporting Council in 2016, consider the going concern basis of preparation to be appropriate in preparing the financial statements. The key conclusions are summarised below.

The Group made a loss for the period of RM0.07m (2018: RM13.66m) and recorded a net cash inflow

from operating activities of RM0.38m (2018: outflow of RM12.08m). At the reporting date the Group

held cash and cash equivalents of RM0.08m (2018: RM0.47m) and had current liabilities of RM69.91m

(2018: RM40.18m).

As described in note 7, amounts of RM10.51m (2018: RM17.91m) are due to the Group from Concord Green Energy Sdn Bhd ("CGE"). A repayment plan was put in place during the year and RM7.40m was repaid. Due to the repayment plan not being upheld subsequent discussions are taking place to re-negotiate the terms of repayment and in the meantime, Serba Dinamik Sdn. Bhd. and one of the executive directors, have guaranteed the value of the debt.

As described in note 8, amounts of RM63.35m (2018: RM38.33m) are due to the Group from Megagreen Energy Sdn Bhd ("MGE"). Further debts arose during the financial period of approximately RM25.02m (2018: RM1.27m) from MGE. The repayment arrangement put in place during the year recovered RM3.13m. As a result of re-negotiations taking place to acquire two (2) biogas power plants located in Perak, in part exchange for some of the receivables this repayment arrangement was put on hold. These acquisitions completed in Q3 2020 and further negotiations are taking place to acquire an additional three (3) biogas power plants and is expected to be finalised upon satisfactory outcome from the due diligence exercise.

The Directors consider the amounts owing to be recoverable in full as a result of negotiations being undertaken.

The Group has also received a letter of support from one of its largest shareholders, Serba Dinamik Sdn. Bhd. giving its willingness to continue to fund the Group.

COVID-19 has been identified as having a significant impact on the Group in the 2020 financial year due to public lockdown. However, as restrictions have been eased and activity is increasingly resuming, the Directors continue to believe that the Group remains viable for the foreseeable future.

The Directors prepared financial projections and plans for a period of at least 12 months from the date of approval of these financial statements. On assessment of the Group's future cash flows, the new financing arrangements that have been made available from the SME Bank loan (detail in note 36), as well as the agreed letter of support from Serba Dinamik Sdn. Bhd. and an assessment of their willingness to perform under this the Directors believe the Group has the ability to continue as a going concern for at least 12 months.

40

3. BASIS OF CONSOLIDATION

The consolidated financial statements comprise the financial information of the Company and its subsidiaries made up to the end of the reporting period. Control is achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. The consolidated financial statements present the results of the Company and its subsidiaries and joint arrangements as if they formed a single entity. Inter-company transactions and balances between Group companies are therefore eliminated in full.

The financial information of subsidiaries is included in the Group's financial statements from the date that control commences until the date that control ceases.

On 6 May 2016, the Company entered into agreements with all of the shareholders of BiON Ventures

Sdn Bhd ("Green & Smart Ventures Sdn Bhd") for a share for share exchange regarding the ordinary shares in BiON plc and ordinary shares in BiON Ventures. As a result of this transaction, the ultimate shareholders in the Company received shares in BiON plc in direct proportion to their original shareholdings in BiON Ventures.

The acquisition of BiON Ventures by the Company was that of a re-organisation of entities which were under common control. As such, that combination also falls outside the scope of IFRS 3 'Business Combinations' (Revised 2008). The Directors have, therefore, decided that it is appropriate to reflect the combination using the merger basis of accounting in order to give a true and fair view. No fair value adjustments were made as a result of that combination.

CHANGES IN ACCOUNTING POLICIES

Standards issued and applied for the first time in 2019

The following new and revised Standards and Interpretations have been adopted in the current year.

• Amendments to IFRS 9 Financial Instruments
• IFRS 16 Leases
• IFRS 15 Revenue Contracts with Customers
• Amendments to IAS 28 Investments in Associates and Joint Ventures

With the exception of IFRS 16 the adoption of these standards has not had a material impact on the financial statements.

Standards issued and not yet effective

There are no new standards, amendments and interpretations to existing standards that have been published which have not been adopted.

IFRS 9 Financial Instruments

The Group applied IFRS 9 retrospectively, with an initial application date of 1 January 2019. The Group has not restated comparative information which continues to be reported under IAS 39 and the disclosure requirements of IFRS 7 Financial Instruments: Disclosures relating to items within the scope of IAS 39. The impact arising from IFRS 9 adoption was included in the opening retained earnings and other components of equity at the date of initial application.

1. Classification and measurement
   Under IFRS 9, debt instruments are subsequently measured either at fair value through profit or loss (FVPL), amortised cost or fair value through other comprehensive income (FVOCI). The classification is based on two criteria: The Group's business model for managing the assets; and whether the instruments' contractual cash flows represent 'solely payments of principal and interest' on the principal amount outstanding.
   The assessment of the Group's business model was made as of the date of initial application, 1
   January 2019. The assessment of whether contractual cash flows on debt instruments solely

41

comprised of principal and interest was made based on the facts and circumstances as at the initial recognition of the assets.

The classification and measurement requirements of IFRS 9 did not have a significant impact to the Group. The Group continued measuring at fair value all financial assets previously held at fair value under IAS 39. The following are the changes in the classification and measurement of the Group's financial assets:

• Trade and other receivables classified as receivables as at 31 December 2018 are held to collect contractual cash flows and give rise to cash flows representing solely payments of principal and interest. These were classified and measured as debt instruments at amortised cost beginning 1 January 2019.
• Unquoted equity securities classified as available-for-sale (AFS) financial assets as at 31 December 2018 were classified and measured as equity instruments designated at FVOCI beginning 1 January 2019. The Group elected to classify irrevocably its unquoted equity securities under this category at the date of initial application as it intends to hold these investments for long-term appreciation. There was an impairment loss of RM150,000 recognised in profit or loss for these investments in prior periods. In addition, all of the investments in unquoted equity securities was measured at cost under IAS 39. Upon adoption of IFRS 9, the Group measured the unquoted equity security at FVOCI.

The Group has not designated any financial liabilities at FVPL. There are no changes in classification and measurement for the Group's financial liabilities.

1. Impairment
   The adoption of IFRS 9 has fundamentally changed the Group's accounting for impairment losses for financial assets by replacing IAS 39's incurred loss approach with a forward-looking expected credit loss (ECL) approach. IFRS 9 requires the Group to recognise an allowance for ECLs for all debt instruments not held at FVPL.
   There is no impact on the impairment amount of the Group upon adoption of IFRS 9 as at 1 January 2019.

IFRS 16 Leases

IFRS 16 is effective from 1 January 2019 and supersedes IAS 17 Leases. The standard eliminates the classification of leases as either operating or finance leases and introduces a single accounting model. Lessees are required to recognise a right-of-use asset and related lease liability for their operating leases and show depreciation of leased assets and interest on lease liabilities separately in the statement of comprehensive income. The standard sets out the principles for the recognition, measurement, presentation and disclosure of leases and requires lessees to recognise substantially all leases on the statement of financial position.

The Group adopted IFRS 16 effective 1 January 2019 using the modified retrospective method of adoption. Under this method, the standard is applied retrospectively with the cumulative effect of initially applying the standard recognised at the date of initial application as an adjustment to the opening balance of retained earnings. Accordingly, prior year financial information has not been restated and will continue to be reported under IAS 17 Leases. The right-of-use asset and lease liability have initially been measured at the present value of remaining lease payments, with the right-of-use asset being subject to certain adjustments.

42

1. Practical expedients applied

In applying IFRS 16, the Group elected to apply the following practical expedients permitted by the standard:

1. • The Group has elected not to reassess contracts that were not identified as leases under IAS 17 and IFRIC 4 to determine whether there is a lease under IFRS 16. Therefore, a definition of a lease under IFRS 16 was applied only to contracts entered into or modified on or after 1 January 2019;
   • Applying a single discount rate to a portfolio of leases with similar characteristics;
   • Relying on previous assessments as to whether leases are onerous as an alternative to performing an impairment review - there were no onerous contracts as at 1 January 2019;
   • Accounting for operating leases with a remaining lease term of less than 12 months as at 1 January 2019 as short-term leases;
   • Excluding initial direct costs for the measurement of the right-of-use asset at the date of the initial application; and
   • Using hindsight in determining the lease term where the contract contains options to extend or terminate the lease.
2. Measurement of lease liabilities

The following table reconciles the opening balance for the lease liabilities as at 1 January 2019 based upon the operating lease obligations as at 31 December 2018:

1. Measurement of right-of-use assets

The associated right-of-use assets for land leases were measured on a modified retrospective basis. The right-of-use assets for the leases were recognised based on the carrying amount as if the standard had always been applied, using the incremental borrowing rate at the date of initial application.

1. Adjustments recognised in the statement of financial position on 1 January 2019 The change in accounting policy affected the following items on 1 January 2019:

The Group solely has lease contracts in relation to land.

43

IFRS 15 Revenue Contracts with Customers

IFRS 15 supersedes IAS 11 Construction Contracts, IAS 18 Revenue and related interpretations and it applies, with limited exceptions, to all revenue arising from contracts with customers. IFRS 15 establishes a five-step model to account for revenue arising from contracts with customers and requires that revenue be recognised at an amount that reflects the consideration to which an entity expects to be entitled in exchange for transferring goods or services to a customer.

IFRS 15 requires entities to exercise judgement, taking into consideration all of the relevant facts and circumstances when applying each step of the model to contracts with their customers. The standard also specifies the accounting for the incremental costs of obtaining a contract and the costs directly related to fulfilling a contract. In addition, the standard requires extensive disclosures.

The Group adopted IFRS 15 using the modified retrospective method of adoption with the date of initial application of 1 January 2019. Under this method, the standard can be applied either to all contracts at the date of initial application or only to contracts that are not completed at this date. The Group elected to apply the standard to those contracts that are not completed as at 1 January 2019. The adoption of IFRS 15 didn't affect the opening retained earnings and other components of equity at the date of initial application.

4. SIGNIFICANT ACCOUNTING POLICIES

4.1 CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS

Estimates and judgements are continually evaluated by the directors and management and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The estimates and judgements that affect the application of the Group accounting policies and disclosures, and have a significant risk of causing a material adjustment to the carrying amounts of assets, liabilities, income and expenses are discussed below: -

1. Impairment of assets
   When the recoverable amount of an asset is determined based on the estimate of the value-in-use of the cash-generating unit to which the asset is allocated, the management is required to make an estimate of the expected future cash flows from the cash-generating unit and also to apply a suitable discount rate in order to determine the present value of those cash flows.
2. Impairment of trade and other receivables
   An impairment loss is recognised when there is objective evidence that a financial asset is impaired. Management specifically reviews its loans and receivable financial assets and analyses historical bad debts, customer concentrations, customer creditworthiness, current economic trends and changes in the customer payment terms when making a judgement to evaluate the adequacy of the allowance for impairment losses. Where there is objective evidence of impairment, the amount and timing of future cash flows are estimated based on historical loss experience for assets with similar credit risk characteristics. If the expectation is different from the estimation, such difference will impact the carrying value of receivables.

44

1. 1. Construction contracts
      As described in note 4.13, the Group's accounting approach reflects a sound judgement as potential losses on contract are being considered and reflected with its probability immediately upon occurrence while contract revenue which cannot be estimated reliably is realised only after confirmed by written agreement. The carrying amounts of the Group's construction contracts due from/(to) customers at the end of the reporting period/year are disclosed in note 9 including any allowance for impairment if there is a material uncertainty to fully recover costs of each contract.
2. FUNCTIONAL AND FOREIGN CURRENCIES
3. 1. Transactions and balances
      Transactions in foreign currencies are converted into the respective functional currencies on initial recognition, using the exchange rates approximating those ruling at the transaction dates. Monetary assets and liabilities at the end of the reporting period are translated at the rates ruling as of that date. Non-monetary assets and liabilities are translated using exchange rates that existed when the values were determined. All exchange differences are recognised in profit or loss.
   2. Foreign operations
      Assets and liabilities of foreign operations are translated to RM at the rates of exchange ruling at the end of the reporting period. Revenues and expenses of foreign operations are translated at exchange rates approximating those ruling at the dates of the transactions. All exchange differences arising from translation are taken directly to other comprehensive income and accumulated in equity under the foreign exchange translation reserve. On the disposal of a foreign operation, the cumulative amount recognised in other comprehensive income relating to that particular foreign operation is reclassified from equity to profit or loss.
4. FINANCIAL INSTRUMENTS

4.3.1 Financial Assets

On initial recognition, financial assets are classified as either financial assets at fair value through profit or loss, held-to-maturity investments, loans and receivables financial assets, or available-for-sale financial assets, as appropriate. The Group currently holds financial assets as:

1. Loans and receivables
   These assets are non-derivative financial assets that have fixed or determinable payments that are not quoted in an active market. They arise through the provision of services to customers (trade receivables). They are initially recognised at fair value plus transaction costs that are directly attributable to the acquisition or issue and subsequently carried at amortised cost using the effective interest method less provision for impairment. The effect of discounting on these financial instruments is not considered to be material.
   Impairment provisions are recognised when there is objective evidence (such as significant financial difficulties on the part of the counterparty or default or significant delay in payment) that the Group will be unable to collect all the amounts due under the term's receivable. The amount of such a provision being the difference between the net carrying amount and the present value of the future expected cash flows associated with the impaired receivable. For trade receivables, such provisions are recorded in a separate allowance account with the loss being recognised within administrative expenses in the income statement. On confirmation that the

45

trade receivable will not be collectable, the gross carrying value of the asset is written off against the associated provision.

4.3.2 Financial Liabilities

All financial liabilities are initially measured at fair value plus directly attributable transaction costs and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the reporting date.

4.3.3 Equity Instruments

Instruments classified as equity are measured at cost and are not remeasured subsequently.

a) Ordinary shares

Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from proceeds.

4.3.4 Derecognition

A financial asset or part of it is derecognised when, and only when, the contractual rights to the cash flows from the financial asset expire or the financial asset is transferred to another party without retaining control or substantially all risks and rewards of the asset. On derecognition of a financial asset, the difference between the carrying amount and the sum of the consideration received (including any new asset obtained less any new liability assumed) and any cumulative gain or loss that had been recognised in equity is recognised in profit or loss.

A financial liability or a part of it is derecognised when, and only when, the obligation specified in the contract is discharged or cancelled or expires. On derecognition of a financial liability, the difference between the carrying amount of the financial liability extinguished or transferred to another party and the consideration paid, including any non-cash assets transferred or liabilities assumed, is recognised in profit or loss.

4.4 PROPERTY, PLANT AND EQUIPMENT

1. Owned Assets
   Items of property, plant and equipment are stated at cost less accumulated depreciation and any accumulated impairment losses, if any. The cost of an asset comprises its purchase price and any directly attributable costs of bringing the asset to the location and condition for its intended use.
2. Assets under construction
   Assets under construction are items of property, plant and equipment that are yet to be completed or ready for use. These are held at historical cost less any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.
   Depreciation is not provided until such a time that the asset is capable of operating in the manner intended by management. Upon completion of the asset, the assets will be carried at fair value determined annually by the directors.

46

1. Depreciation
   Depreciation is charged to profit or loss (unless it is included in the carrying amount of another asset) on the straight-line basis to write off the depreciable amount of the assets net of the estimated residual values over their estimated useful lives. Assets under construction are depreciated from the date they are ready for use. Depreciation of an asset does not cease when the asset becomes idle or is retired from active use unless the asset is fully depreciated. The principal annual rates used for this purpose are: -

The depreciation method, useful lives and residual values are reviewed, and adjusted if appropriate, at the end of each reporting period to ensure that the amounts, method and periods of depreciation are consistent with previous estimates and the expected pattern of consumption of the future economic benefits embodied in the items of the property, plant and equipment.

1. Subsequent expenditure
   Subsequent costs are included in the asset's carrying amount or recognised as a separate asset, as appropriate, only when the cost is incurred and it is probable that the future economic benefits associated with the asset will flow to the Group and the cost of the asset can be measured reliably. The carrying amount of parts that are replaced is derecognised. The costs of the day-to-day servicing of property, plant and equipment are recognised in profit or loss as incurred. Cost also comprises the initial estimate of dismantling and removing the asset and restoring the site on which it is located for which the Group is obligated to incur when the asset is acquired, if applicable.
   An item of property, plant and equipment is derecognised upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising from de-recognition of the asset is recognised in profit or loss.

4.5 INTANGIBLE ASSETS

Intangible assets acquired separately are measured on initial recognition at cost. Following initial recognition, intangible assets are carried at cost less accumulated amortisation and any accumulated impairment losses (note 5). The useful lives of intangible assets are assessed to be either finite or indefinite.

Intangible assets with a finite life are amortised on straight-line basis over the estimated economic useful life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortisation period and the amortisation method for an intangible asset with a finite useful life are reviewed at least at each financial period / year end.

The amortisation expense on intangible assets with finite useful lives is recognised in the profit or loss in the expense category consistent with the function of the intangible asset.

47

1. 1. Trademark
      Trademarks are stated at cost less accumulated amortisation and any impairment losses (note 5). Trademarks are tested for impairment annually or more frequently if the events or changes in circumstances indicate that the carrying value may be impaired either individually or at cash generating unit level. Trademarks are amortised over a period of ten (10) years.
2. IMPAIRMENT
3. 1. Impairment of Non-Financial Assets
      The carrying values of assets, are reviewed at the end of each reporting period for impairment when there is an indication that the assets might be impaired. Impairment is measured by comparing the carrying values of the assets with their recoverable amounts. The recoverable amount of the assets is the higher of the assets' fair value less costs to sell and their value-in-use, which is measured by reference to discounted future cash flow.
      An impairment loss is recognised in profit or loss immediately.
      When there is a change in the estimates used to determine the recoverable amount, a subsequent increase in the recoverable amount of an asset is treated as a reversal of the previous impairment loss and is recognised to the extent of the carrying amount of the asset that would have been determined (net of amortisation and depreciation) had no impairment loss been recognised. The reversal is recognised in profit or loss immediately.
4. INCOME TAXES
   Income tax for the period comprises current and deferred tax.
   Current tax is the expected amount of income taxes payable in respect of the taxable profit for the reporting period and is measured using the tax rates that have been enacted or substantively enacted at the end of the reporting period, and any adjustment to tax payable in respect of previous financial years.
   Deferred tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements.
   Deferred tax liabilities are recognised for all taxable temporary differences other than those that arise from the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction, affects neither accounting profit nor taxable profit.
   Deferred tax assets are recognised for all deductible temporary differences, unused tax losses and unused tax credits to the extent that it is probable that future taxable profits will be available against which the deductible temporary differences, unused tax losses and unused tax credits can be utilised. The carrying amounts of deferred tax assets are reviewed at the end of each reporting period/year and reduced to the extent that it is no longer probable that sufficient future taxable profits will be available to allow all or part of the deferred tax assets to be utilised.
   Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year/period when the asset is realised or the liability is settled, based on the tax rates that have been enacted or substantively enacted at the end of the reporting year/period.
   Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when the deferred income taxes relate to the same taxation authority.

48

Deferred tax relating to items recognised outside profit or loss is recognised outside profit or loss. Deferred tax items are recognised in correlation to the underlying transactions either in other comprehensive income or directly in equity. Deferred tax arising from a business combination is included in the resulting goodwill or excess of the acquirer's interest in the net fair value of the acquiree's identifiable assets, liabilities and contingent liabilities over the business combination costs.

1. CASH AND CASH EQUIVALENTS
   Cash and cash equivalents comprise cash in hand, bank balances, demand deposits, bank overdrafts and short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value with original maturity periods of three months or less.
2. EMPLOYEE BENEFITS
3. 1. Short-termbenefits

Wages, salaries, paid annual leave and sick leave, bonuses and non-monetary benefits are measured on an undiscounted basis and are recognised in profit or loss and included in the development costs, where appropriate, in the period/year in which the associated services are rendered by employees of the Group.

1. Defined contribution plans
   The Group's contribution to defined contribution plans are recognised in profit or loss in the period/year to which they relate. Once the contributions have been paid, the Group has no further liability in respect of the defined contribution plans.

4.10 REVENUE AND OTHER INCOME

Revenue is recognised at an amount that reflects the consideration to which the entity expects to be entitled in exchange for transferring goods or services to a customer net of sales taxes and discounts. A performance obligation may be satisfied at a point in time or over time. The amount of revenue recognised is the amount allocated to the satisfied performance obligation.

1. Revenue from construction contracts
   Revenue from construction contracts is recognised in line with IFRS 15 based on the percentage of completion method based on works performed. The stage of completion is measured by reference to the actual cost incurred to date to estimated total cost for each contract.
   Where the outcome of a contract cannot be reliably estimated, contract revenue is recognised to the extent of contract costs incurred that are likely to be recoverable. Contract costs are recognised as expenses in the period in which they are incurred.
   When it is probable that total contract costs will exceed total contract revenue, the expected loss is recognised as an expense immediately.

1. Government grants
   Grants that compensate the Group for expenses incurred are recognised in profit or loss on a systematic basis over the period necessary to match them with the related costs which they are intended to compensate for.

49

Grants that compensate the Group for the costs of assets are recognised in profit or loss on a systematic basis over the expected life of the related asset.

1. Revenue from Sale of Electricity
   Revenue from the sale of electricity generated from the renewable energy plant is recognised as and when the electricity is delivered to the off-taker, based on the invoiced value of sale of electricity, computed at a predetermined rate. Accrued unbilled revenues are reversed in the following month when actual billing occurs.

1. BORROWING COSTS
   Borrowing costs, directly attributable to the acquisition, construction or production of a qualifying asset, are capitalised as part of the cost of those assets, until such time as the assets are ready for their intended use or sale. Capitalisation of borrowing costs is suspended during extended periods in which active development is interrupted.
   All other borrowing costs are recognised in the profit or loss as expenses in the period in which they are incurred. No interest costs were capitalised during the period.
   Investment income earned on the temporary investment of specific borrowing pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation.
2. CONTINGENT LIABILITIES
   A contingent liability is a possible obligation that arises from past events and whose existence will only be confirmed by the occurrence of one or more uncertain future events not wholly within the control of the Group. It can also be a present obligation arising from past events that is not recognised because it is not probable that an outflow of economic resources will be required, or the amount of obligation cannot be measured reliably.
   A contingent liability is not recognised but is disclosed in the notes to the financial statements. When a change in the probability of an outflow occurs so that the outflow is probable, it will then be recognised as a provision.
3. CONSTRUCTION CONTRACTS

1. Contract revenue
   Revenue from construction contracts is recognised as described in note 4.10(i).
2. Amount due from / (to) customer for contract work
   Amount due from / (to) customer for contract work is the net amount of cost incurred for construction and contract-in-progress plus profit attributable to contract-in-progress less foreseeable losses, if any, and progress billings. Contract cost incurred to date include costs directly related to the contract or attributable to contract activities in general and costs specifically chargeable to the customer under the terms of the contract.

50

5. INTANGIBLE ASSETS

(a) Trademark

The trademarks "GRASS", "POME-MAS" and "GREENPAK" are registered in Malaysia in respect of patented wastewater and bio-waste treatment technologies. These trademarks have been granted for an indefinite period, however, they are being amortised over ten (10) years in line with Management's best estimate of their expected useful life.

The remaining amortisation period of trademarks is between one (1) to three (3) years, the remaining amortisation period of patents is between six (6) to twelve (12) years.

(b) Impairment Test

The Group has assessed the recoverable amounts of intangible assets and determined that no impairment is required. The recoverable amounts of the cash-generating units ("CGU") are determined using the value in use approach, and this is derived from the present value of the future cash flows from each CGU computed based on the following key assumptions:

1. Cash flows are extrapolated to 18 years based on management's two-year business plan.
2. Discount rates used, 7%, for the cash flows discounting purpose reflects specific risks relating to the relevant CGU.
3. Growth rate for a CGU, 2%, is determined based on the management's estimate of the industry trends and past performances of the CGU.
4. Profit margins are projected based on the industry trends and historical profit margin achieved.

Management believes that there is no reasonable possible change likely to materially cause the CGU carrying amount to exceed its recoverable amount if applied to the above key assumptions.

51

6. PLANT AND EQUIPMENT

52

6. PLANT AND EQUIPMENT (CONT'D)

1. Included in the assets of the Group at the end of the reporting period were motor vehicles with a total net book value of RM0.20m (2018: RM0.37m), which were acquired under hire purchase terms.
2. Assets under construction represents biogas power plant under construction. It is subject to depreciation only when completed and ready for use. No interest was capitalised during the financial year, but total interest capitalised to date included in the Asset under construction amounts to RM0.54m (2018: RM0.54m).
3. Industrial building with carrying amount of approximately RM36.69m (2018: RM19.43m) and
   Assets under construction with carrying amount of approximately RM7.54m (2018: RM21.42m) are pledged against the banking facility (note 17).
4. Acquisition of plant and equipment: -

7. TRADE AND OTHER RECEIVABLES

1. The Group's normal credit terms range from 90 to 120 days (2018: 90 to 120 days). Other credit terms are assessed and varied on a case-by-case basis.
2. Trade and other receivables that are individually determined to be impaired relate to customers that have defaulted on payments or the amount due from third parties considered irrecoverable.
3. Included in the Trade Receivables is an amount of RM10.51m (2018: RM17.91m) from CGE.

53

• For the financial period to 31 December 2018, Concord Green Energy Sdn Bhd ("CGE") is no longer classified as a related party following the Group's disposal of its interest in the Company. The outstanding amount is now reflected as a Trade Receivable (Note 7).

Amounts owing by related parties principally comprise trade debts due from Megagreen Energy Sdn Bhd ("MGE"). The amounts due are collectible in cash, have arisen in the ordinary course of the business of the Group and are subject to credit terms of 30 days. The amounts owing are analysed as follows:

During the year, a repayment arrangement was structured with MGE for a monthly payment of RM3.0m. During the year RM3.13m was received, but as a result of re-negotiations taking place to acquire two (2) biogas power plants located in Perak, in part exchange for some of the receivables this repayment arrangement was put on hold. . Post year end these have been acquired from MGE with the deposits for these plants being used to offset the receivable due to the Group of RM13.80m. Further negotiations are taking place to acquire three (3) further biogas power plants and is expected to be finalised upon satisfactory outcome from the due diligence exercise.

55

9. DUE FROM CUSTOMERS FOR CONSTRUCTION CONTRACTS

10. CASH AND CASH EQUIVALENTS

Cash and cash equivalents included in the cash flow statement comprise the following amounts:

11. STATED CAPITAL

During the financial period on 19 July 2018, the Company issued 51,806,000 Ordinary Shares (representing approximately 15% of the Company's issued share capital as enlarged by the Shares) at 6.19p per Ordinary Share to raise approximately RM17.10m (£3.21m, at an exchange rate of RM5.3295 to £1).

At 31 December 2019, the Company's issued share capital was 345,375,812 ordinary shares.

There were no further movements in the Company's issued share capital during the financial year.

56

12. LEASES

Group as a lessee

The Group has lease contracts for lands. The Group's obligations under these leases are secured by the lessor's title to the leased assets. The Group is restricted from assigning and subleasing the leased assets.

The Group also has certain leases of office equipment with low value. The Group applies the 'lease of low-value assets' recognition exemptions for these leases.

1. Right of use assets

57

d) Total cash outflow

The Group had a total cash outflows for leases of RM935,000 in current financial year.

13. TRADE AND OTHER PAYABLES

The normal credit terms granted to the Group by the suppliers are 90 days (2018: 90 days) from invoice date.

14. SHORT-TERM BORROWINGS

*Mezzanine loan

1. On 23 May 2019, the Group procured a 12-month interest free loan of RM8.40m with Tuan Syed Nazim Syed Faisal for working capital purposes. This has subsequently been converted to shares post year-end, see note 36.
2. On 13 August 2019, the group further procured a 6-month loan of approximately RM0.51m with a UK-based lender at an interest rate of 1.5% per month for working capital purposes. As at year end, the principle remains outstanding.

58

15. HIRE PURCHASE PAYABLES

The hire purchase payables of the Group at the end of the reporting period bare effective interest rates ranging from 5.20% to 5.36% (2018: 5.20% - 5.36%).

16. DEFERRED GRANT INCOME

The Group received a government grant in financial years 2007 and 2008 which was provided for the project "Greenpak", to develop a new individual septic tank using Upflow Anaerobic Sludge Blanket principle. The grant income is amortised on a systematic basis over the useful life of the related patent.

During the financial period ended 31 December 2019, an amortised amount of RM13,000 was recognised (15 months of 2018: RM16,000) as other income in profit or loss.

59

17. TERM LOANS

The term loans are secured against: -

1. Fixed and floating charges over the present and future assets;
2. Assignment of all rights, interest and benefits and the proceeds from the sales of the electricity;
3. Assignment of all rights, benefits interest and title under industrial building;
4. A guarantee by Credit Guarantee Corporation Berhad (Term loan 1 only);
5. Joint and severally guaranteed by the Directors of the Company.

Term loan 1 bears effective interest rate at 8% (2018: 8%) per annum and term loan 2 bears effective

interest rate at 5% (2018: 5%) per annum.

During the financial year, due to delayed repayment and the lender being in a position to declare the term loan outstanding as immediately due and payable, the entire term loan was reclassified as a current liability. Thereafter, the term loan was fully repaid on 3 July 2020.

18. DEFERRED TAXATION

19. REVENUE

60

20. OTHER INCOME

1. FINANCE INCOME
   The finance income recognised is in relation to the interest charged for advances given to the related party, at a rate of 18% per annum (1.5% per month) (see note 26 for detail).
2. FINANCE COSTS

61

23. PROFIT BEFORE TAXATION

62

24. INCOME TAX EXPENSE

The Company is regarded as resident for tax purposes in Jersey and on the basis that the Company is neither a financial service company nor a utility company for the purpose of the Income Tax (Jersey) Law 1961, as amended, the Company is subject to income tax in Jersey at a rate of zero per cent.

BiON Sdn Bhd is granted BioNexus status by a government agency, namely Malaysian Bioeconomy Development Corporation Sdn Bhd (previously known as Malaysian Biotechnology Corporation Sdn. Bhd). Therefore, BiON Sdn Bhd is entitled to tax exemption on the statutory business income derived from approved activities over five consecutive years of assessment commencing from the first year in which BiON Sdn Bhd generates statutory income from the relevant approved activities. The tax exemption expired in the financial period ended 31 December 2018. No further exemption has been granted thereafter.

Domestic income tax is calculated at the Malaysian statutory tax rate of 24% (2018: 24%) of the estimated assessable profit for the financial period.

A reconciliation of income tax expense applicable to the profit before taxation at the statutory tax rate to income tax expense at the effective tax rate of the Group is as follows: -

63

25. DIRECTORS' EMOLUMENTS

The amount of remuneration received by each director in the year was as follows:

26. RELATED PARTY TRANSACTIONS

1. Identities of Related Parties
   Parties are considered to be related to the Group if the Group has the ability, directly or indirectly, to control or jointly control the party or exercise significant influence over the party in making financial and operating decisions, or vice versa, or where the Group and the party are subject to common control.
   In addition to the information detailed elsewhere in the financial statements, the Group has related party relationships with its directors, key management personnel and entities within the same group of companies.

64

Other than those disclosed elsewhere in the financial statements, the Group also carried out the following significant transactions with the related parties during the financial period: -

1. Dato' Dr. Sivamohan S. Namasivayam

65

Related parties: -

1. The group via its subsidiary, BiON Sdn Bhd, hold 15% shares in Megagreen Energy Sdn Bhd.
2. K2M Ventures Sdn Bhd ("K2M"), holds 32.52% shares in BiON plc. During the year, K2M waived debts due from the Group amounting to RM1.63m.
3. Mr. Saravanan, who was a director and shareholder in BiON plc for the year ended 31 December 2019, is also one of the appointed Directors in Makmur Hydro Sdn Bhd.
4. Mr. Saravanan, who was a director and shareholder in BiON plc for the year ended 31 December 2019. During the year, all amounts owed to the director were waived and amounts were realised in other income.
5. Mr. Navindran, who was a director and shareholder in BiON plc for the year ended 31 December 2019. During the year, all amounts owed to the director were waived and amounts were realised in other income.
6. Serba Dinamik group of companies, one of the significant shareholders in BiON plc for the year ended 31 December 2019.
7. Syed Nazim Syed Faisal, being an Executive Director in BiON plc for the year ended 31

December 2019.

viii)Aditya Chathlli, being a Non-Executive Director in BiON plc for the year ended 31 December 2019.

1. 1. Datuk Dr. Hj. Radzali Hassan, being a Non-Executive Director in BiON plc for the year ended 31 December 2019.
   2. Dato' Dr. Sivamohan S. Namasivayam, who was a Non-Executive Director in BiON plc, resigned on 25 October 2018.
   3. Sivadas Kumar, who was an Executive Director in BiON plc, resigned on 25 October 2018.
2. Compensation of key management personnel
   The remuneration of directors and other members of key management personnel during the period are as follows: -

The key management personnel are those personnel having authority and responsibility for planning, directing and controlling the activities within the Group, either directly or indirectly.

The payment of emoluments to the director is disclosed in the remuneration report.

66

27. EARNINGS PER SHARE

The calculation of earnings per share is based on the following earnings and number of shares:

Earnings per share has been calculated by dividing the profit or loss for the year attributable to equity holders of the Group by the weighted average number of ordinary shares in issue during the year.

The diluted number of shares includes those reserved under warrants (note 32).

28. RESERVES

1. Foreign currency translation reserves
   The foreign currency translation reserves arose from the translation of the financial information of foreign subsidiaries and are not distributable by way of dividends.
2. Merger reserves
   The accounting treatment for Group reorganisations is scoped out of IFRS 3. Accordingly, as required under IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors, the Group has referred to current UK GAAP to assist its judgement in identifying a suitable accounting policy. The introduction of the holding company, BiON plc, had been accounted for as a capital reorganisation using the merger accounting principles prescribed under current UK GAAP. Therefore, the consolidated financial statements of BiON plc are presented as if the Company has always been the holding company for the Group.
   The use of merger accounting principles has resulted in a balance on Group capital and reserves that have been classified as a merger reserve and included in the Group's shareholders' funds. The consolidated financial statements include the results of the Company and all its subsidiary undertakings made up to the same accounting date.

67

29. CONTINGENCIES

No provisions are recognised on the following matters as it is not probable that a future sacrifice of economic benefits will be required, or the amount is not capable of reliable measurement: -

The Group has provided Megagreen Energy with a corporate guarantee in support of a loan facility. Credit Guarantee Corporation Malaysia Berhad has confirmed that repayment of the 60% of the amount borrowed by Megagreen under the facility is guaranteed by Credit Guarantee Corporation Malaysia Berhad up to June 2025 pursuant to the Green Technology Financing Scheme - established by the Malaysian government. In July 2020, the loan was partially repaid, leaving a balance of RM9.5m. On that basis, the Directors expect the exposure of BiON under the guarantee to be limited to approximately RM3.8m (2018: RM14.1m).

30. CAPITAL COMMITMENTS

At 31 December, the Group had the following capital commitments in respect to plant & equipment:

31. OPERATING SEGMENTS

1. Operating segments

Operating segments are prepared in a manner consistent with the internal reporting provided to the management as its chief operating decision maker in order to allocate resources to segments and to assess their performance. Currently the Group operates under two operating segments providing consulting and contract services to customers in the renewable energy sector and the supply of power to National Grid.

Information on geographical segments is not presented as the Group operates wholly in Malaysia where all of its assets and liabilities are located.

68

The information provided to management for the reportable segments during each year/period are as follows:

1. Information about major customers

During the year, the following customers contributed more than 10% of the revenue for the Group:

69

32. WARRANT INSTRUMENTS

On 6 May 2016, the Company granted 1,383,333 warrants to S.P. Angel Corporate Finance LLP, the Company's previous nominated adviser, at the exercise price of 9 pence each, which were exercisable immediately upon grant, with an expiring date of 5 May 2021.

On 19 June and 28 June 2017, the Company issued 5,848,680 warrants, at the exercise price of an average closing bid price at three trading days prior to the day of notice to exercise, to subscribers to a private placing arranged by Charles Street Securities Europe LLP ("CSS"), and to CSS as part of the fee arrangements for arranging the placement. Of the total warrants issued, 2,777,778 were issued to CSS as fees payable in connection with that placement. The warrants issued to subscribers are outside the scope of IFRS 2. In accordance with IFRS 2 the fair value of the warrants issued as fees for the placement services provided has been estimated as RM220,000. This has been recognised within the stated capital component of equity as the costs were directly incurred in raising the related equity funds.

33. ULTIMATE CONTROLLING PARTIES

At the reporting date, the Directors consider there is no ultimate controlling party.

70

34. FINANCIAL INSTRUMENTS

The Group's activities are exposed to a variety of market risks (including foreign currency risk, interest rate risk and equity price risk), credit risks and liquidity risks. The Group's overall financial risk management policy focuses on the unpredictability of finance market and seek to minimise potential adverse effects on the Group's financial performance by having in place adequate financial resources for the development of the Group's business whilst managing its market risk, credit risk and liquidity risk.

The Group holds the following financial instruments:

34.1 FINANCIAL RISK MANAGEMENT POLICIES

The following sections provide details on the Group's exposure to the abovementioned financial risks and the objectives, policies and processes for the management of these risks.

34.1.1 MARKET RISK

1. Foreign Currency Risk

The Group is exposed to foreign currency risk on transactions and balances that are denominated in currencies other than functional currency. The currencies giving rise to this risk are primarily the United States Dollar ("USD") and Great British Pound ("GBP"). Foreign currency risk is monitored closely on an on-going basis to ensure that the net exposure is at an acceptable level. At the end of the reporting period, the Group does not have any derivative financial instruments used to hedge foreign currency risk.

71

34. FINANCIAL INSTRUMENTS (CONT'D)

34.1.1 MARKET RISK (CONT'D)

The Group exposure to foreign currency risk, based on the carrying amounts at the reporting date is as follows:

72

34. FINANCIAL INSTRUMENTS (CONT'D)

34.1.1 MARKET RISK (CONT'D)

73

34. FINANCIAL INSTRUMENTS (CONT'D)

34.1.1 MARKET RISK (CONT'D)

1. Foreign Currency Risk (cont'd)

The following details the sensitivity analysis of the Group's profit after tax to a reasonably possible change in the foreign currencies at the end of the reporting period with all other variables held constant:

A weakening of the above currencies against Ringgit Malaysia at the reporting date would have had the equal but opposite effect on the above currencies to the amounts shown above, with all other variables held constant.

1. Interest Rate Risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Group's exposure to interest rate risk arises mainly from interest-bearing financial liabilities. The Group's policy is to obtain the most favourable interest rates available. Any surplus funds of the Group will be placed with licensed financial institutions to generate interest income.

The sensitivity analysis is not presented as the sensitivity impact is immaterial because the loan has a fixed interest rate which is subsequently rolled-up into the principal.

1. Equity Price Risk
   The Group does not have any quoted investments and hence is not exposed to equity price risk.

34.1.2 CREDIT RISK

The Group's exposure to credit risk, or the risk of counterparties defaulting, arises mainly from trade and other receivables. The Group manages its exposure to credit risk by the application of credit approvals, credit limits and monitoring procedures on an ongoing basis.

The Group uses ageing analysis to monitor the credit quality of the trade receivables. Any receivables having significant balances past due, which are deemed to have higher credit risk, are monitored individually.

74